BBVA
NKTR icon

Banco Bilbao Vizcaya Argentaria’s Nektar Therapeutics NKTR Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,128
Closed -$365K – 732
2019
Q4 		$365K Buy
+1,128
New +$327K 0.01% 583

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's NKTR Position: Q1 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Nektar Therapeutics (NKTR) in Q1 2020, closing a stake of 1,128 shares — an estimated $365K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in NKTR in Q4 2019 and held it in 1 quarter. The position peaked at $365K in Q4 2019. 245 funds tracked by Wall St. Rank hold NKTR as of Q1 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Nektar Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 1,128 Nektar Therapeutics shares in Q1 2020, an estimated $365K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Nektar Therapeutics in Q4 2019 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Nektar Therapeutics position peaked at $365K in Q4 2019.
  • 245 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q1 2020, filed 13 May 2020.